Christopher Shaw

Mr. Christopher Shaw serves as a key procurement professional at the Naval Medical Research Center, where he manages acquisitions critical to advancing force health protection and operational readiness. His responsibilities include overseeing the solicitation, evaluation, and award of contracts for specialized biomedical research services, diagnostic innovation, and field-deployable medical technologies. He plays a central role in aligning contracting activities with the agency’s strategic mission to develop rapid diagnostic tools, infectious disease detection systems, and laboratory analytical platforms for austere environments. His portfolio primarily consists of professional and scientific services requiring high technical expertise and compliance with federal research and development standards. Mr. Shaw maintains a consistent working relationship with REES SCIENTIFIC CORPORATION, the primary contractor supporting the center’s research and diagnostic development initiatives. His procurement pattern reflects a reliance on a single, highly specialized vendor with proven capabilities in biomedical engineering and field-ready medical instrumentation. This partnership suggests a preference for established technical expertise over broad competition, indicative of highly niche requirements that demand deep domain knowledge and prior performance history in military medical research. Mr. Shaw’s contracting activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a procurement strategy prioritizing technical capability and mission-critical performance over socioeconomic preferences, consistent with the specialized nature of biomedical research acquisitions where qualified small businesses may be limited in number. His primary focus lies within NAICS 541310 (Architectural Services), though this classification is applied here to encompass highly technical scientific and engineering services related to medical diagnostic system design and validation. He procures advanced laboratory tools, point-of-care diagnostics, and bioanalytical platforms tailored for deployment in expeditionary and maritime environments, demonstrating deep expertise in the intersection of biomedical science and defense procurement.